ERK inhibition sensitizes CZ415-induced anti-osteosarcoma activity in vitro and in vivo | |
Yin, Gang[1]; Fan, Jin[2]; Zhou, Wei[3]; Ding, Qingfeng[4]; Zhang, Jun[5]; Wu, Xuan[6]; Tang, Pengyu[7]; Zhou, Hao[8]; Wan, Bowen[9]; Yin, Guoyong[10] | |
刊名 | ONCOTARGET
![]() |
2017 | |
卷号 | 8期号:47页码:82027-82036 |
关键词 | osteosarcoma mTOR CZ415 ERK molecular-targeted therapy |
ISSN号 | 1949-2553 |
DOI | http://dx.doi.org/10.18632/oncotarget.18303 |
URL标识 | 查看原文 |
收录类别 | SCI(E) |
WOS记录号 | WOS:000412683900033 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/5346720 |
专题 | 江苏大学 |
作者单位 | 1.[1]Nanjing Med Univ, Affiliated Hosp 1, Dept Spine Surg, Nanjing 210029, Jiangsu, Peoples R China. 2.Jiangsu Univ, Changzhou Wujin Hosp, Dept Orthopaed, Changzhou 213017, Jiangsu, Peoples R China. 3.[2]Nanjing Med Univ, Affiliated Hosp 1, Dept Spine Surg, Nanjing 210029, Jiangsu, Peoples R China. 4.[3]Nanjing Med Univ, Affiliated Hosp 1, Dept Spine Surg, Nanjing 210029, Jiangsu, Peoples R China. 5.[4]Nanjing Med Univ, Affiliated Hosp 1, Dept Spine Surg, Nanjing 210029, Jiangsu, Peoples R China. 6.[5]Nanjing Med Univ, Affiliated Hosp 1, Dept Spine Surg, Nanjing 210029, Jiangsu, Peoples R China. 7.[6]Nanjing Med Univ, Affiliated Hosp 1, Dept Spine Surg, Nanjing 210029, Jiangsu, Peoples R China. 8.[7]Nanjing Med Univ, Affiliated Hosp 1, Dept Spine Surg, Nanjing 210029, Jiangsu, Peoples R China. 9.[8]Nanjing Med Univ, Affiliated Hosp 1, Dept Spine Surg, Nanjing 210029, Jiangsu, Peoples R China. 10.[9]Nanjing Med Univ, Affiliated Hosp 1, Dept Spine Surg, Nanjing 210029, Jiangsu, Peoples R China. |
推荐引用方式 GB/T 7714 | Yin, Gang[1],Fan, Jin[2],Zhou, Wei[3],et al. ERK inhibition sensitizes CZ415-induced anti-osteosarcoma activity in vitro and in vivo[J]. ONCOTARGET,2017,8(47):82027-82036. |
APA | Yin, Gang[1].,Fan, Jin[2].,Zhou, Wei[3].,Ding, Qingfeng[4].,Zhang, Jun[5].,...&Yin, Guoyong[10].(2017).ERK inhibition sensitizes CZ415-induced anti-osteosarcoma activity in vitro and in vivo.ONCOTARGET,8(47),82027-82036. |
MLA | Yin, Gang[1],et al."ERK inhibition sensitizes CZ415-induced anti-osteosarcoma activity in vitro and in vivo".ONCOTARGET 8.47(2017):82027-82036. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论